Massachusetts Biotechnology Council CEO Issues Innovation Policy Update on June 4, 2026
June 06, 2026
June 06, 2026
CAMBRIDGE, Massachusetts, June 6 -- The Massachusetts Biotechnology Council issued the following statement on June 4, 2026, by CEO Kendalle Burlin O'Connell:
* * *
CEO Innovation Policy Update 06.04.26
A busy week in Washington with real consequences for Massachusetts -from new legislation putting biotech licensing deals under national security review, to a sweeping OMB proposal that would hand political appointees veto power over scientific peer revie . . .
* * *
CEO Innovation Policy Update 06.04.26
A busy week in Washington with real consequences for Massachusetts -from new legislation putting biotech licensing deals under national security review, to a sweeping OMB proposal that would hand political appointees veto power over scientific peer revie . . .
